Pain Management After Gastrointestinal Surgery in Dogs

By Steve Mehler, DVM, DACVS

A dog has just undergone intestinal surgery. What should we give for pain?

The answer requires more than choosing a medication from a discharge list. We need to treat pain from the abdominal incision and the affected organs, while considering hydration, perfusion, renal function, nausea and the condition of the bowel.

My approach is to build a multimodal plan around effective analgesia, then adjust it as the patient recovers. Opioids often play an important early role. Local and regional techniques can address particular sources of pain. NSAIDs require careful selection. Additional medications should earn their place through a plausible indication and a measurable response.

The research also challenges some familiar assumptions. Recent canine studies do not support promising that postoperative lidocaine will improve GI recovery, and they do not justify treating every dog after an intestinal anastomosis with an NSAID.

Start by recognizing the different sources of pain

A gastrotomy opens the stomach. An enterotomy opens the intestine. An intestinal resection and anastomosis removes a segment of bowel and reconnects the remaining ends.

These procedures involve abdominal-wall injury, but their analgesic demands are not identical. Pre-existing obstruction, inflammation, ischemia, bowel manipulation and peritonitis can add substantial visceral pain.

The WSAVA pain guidelines recommend preventive, multimodal analgesia for soft-tissue surgery, with treatment intensity matched to the patient and procedure. These are broad recommendations, not a validated protocol specifically for septic intestinal anastomoses. That distinction matters. A healthy dog undergoing elective abdominal surgery is a useful research model, but it does not reproduce the physiology of a dehydrated dog with necrotic intestine.

Opioids remain important even when GI motility is a concern

For significant immediate postoperative pain, injectable full mu-opioid agonists such as methadone, fentanyl, hydromorphone or morphine are reasonable options within a monitored, individualized plan. The literature reviewed here does not establish one as the best opioid for every canine GI surgery patient. The motility concern is real, but its relationship to clinical recovery is complicated. In a canine experimental study after open abdominal surgery, epidural morphine facilitated the return of a gastric interdigestive migrating complex. That finding illustrates how route, analgesia and postoperative physiology can change the result; it does not establish epidural morphine as a proven treatment for clinical postoperative ileus.

I would therefore avoid two shortcuts: blaming all postoperative GI dysfunction on opioids, or reducing opioid treatment before another effective approach controls the pain. Opioid sparing should mean maintaining comfort with less opioid exposure. It requires assessment of pain and adverse effects together. A dog with persistent abdominal discomfort needs reassessment, not simply a smaller dose because we are worried about motility.

NSAIDs after intestinal surgery need a closer look

NSAIDs can provide useful analgesia, but two different safety questions are often combined: whether the drug can injure the GI tract or kidneys, and whether it can interfere with healing of an intestinal incision.

The first concern is well established. Carprofen labeling describes GI, renal and hepatic adverse effects, identifies dehydration and organ dysfunction as risk factors, and advises avoiding concurrent NSAIDs or corticosteroids. The second question has less direct canine evidence.

What the 721-dog carprofen study found

Riddle and colleagues retrospectively reviewed 721 dogs undergoing surgery for GI foreign-body obstruction. Only 69 received postoperative carprofen: 43 after gastrotomy, 11 after enterotomy and 15 after enterectomy. Thirteen dogs developed intestinal dehiscence; none had received carprofen. The researchers detected no association between carprofen and dehiscence or ileus. This is reassuring observational evidence, but exposure was uncommon and treatment was not randomized. Clinicians may have preferentially given carprofen to healthier patients. Most importantly, only 15 treated dogs underwent enterectomy, leaving considerable uncertainty for intestinal anastomoses.

My interpretation is that selected postoperative use deserves consideration. The study does not establish universal safety, apply equally to other NSAIDs, or resolve the question in dogs with compromised bowel or septic peritonitis.

Why human studies still deserve attention

A Danish cohort study of patients undergoing colorectal cancer surgery associated postoperative diclofenac with anastomotic leakage requiring reoperation; ibuprofen did not show the same adjusted association. That is a reason to take the healing question seriously. It is not a canine carprofen risk estimate. Species, medication, disease, surgical site and study design all affect how far we can extrapolate.

How I would translate the evidence into practice

I would reassess NSAID suitability after correcting hypovolemia and reviewing perioperative blood pressure, renal function, recent medications and the surgeon’s assessment of the bowel. Active ulceration, perforation, ongoing shock, renal perfusion concerns or a clinically fragile anastomosis would make me favor other analgesic options initially. This is a cautious clinical synthesis, rather than a selection rule validated by the carprofen study. GI surgery alone should not be treated as a permanent prohibition. Equally, stable bloodwork does not by itself establish that an NSAID is appropriate immediately after resection of compromised intestine.

Local anesthesia helps but the target matters

An incisional block addresses pain from the surgical wound. A transversus abdominis plane, or TAP, block principally targets nerves supplying the abdominal wall and parietal peritoneum. It should not be assumed to provide dependable analgesia for intestinal or mesenteric pain. There is supportive canine evidence. A randomized trial of TAP blocks using bupivacaine with dexmedetomidine or a liposomal bupivacaine formulation found lower pain scores and rescue requirements after elective ovariohysterectomy.

But results vary. In a 2025 randomized laparoscopic ovariectomy study, TAP and quadratus lumborum blocks reduced cardiovascular responses at abdominal incision compared with controls, while neither reliably prevented responses to ovarian traction. All analyzed dogs ultimately needed intraoperative rescue analgesia.

These findings support using regional techniques for the pain they can address, while preserving systemic rescue treatment. They also caution against describing any fascial-plane block as complete visceral analgesia. For a GI patient, the choice of technique should reflect incision location, anticipated duration, expertise and the patient’s suitability. Total local-anesthetic exposure needs to account for every block and infusion; combining techniques does not make their doses independent.

IV lidocaine deserves a more cautious claim

Burns and colleagues conducted a randomized, blinded trial in 24 dogs undergoing GI foreign-body surgery. All received intraoperative lidocaine; after recovery, dogs received either lidocaine at 1.8 mg/kg/hour or saline for 24 hours. Continuing lidocaine did not significantly improve pain or nausea scores, hospitalization time, time to defecation, or vomiting/regurgitation. More dogs in the lidocaine group required rescue analgesia.

The study was small, and overall pain scores were low. It tested continuation of one postoperative regimen, not intraoperative lidocaine versus none. Nevertheless, it gives no support for promising an opioid-sparing benefit from that regimen.

Human evidence also warrants restraint. The ALLEGRO trial analyzed 557 adults after minimally invasive colon surgery and found no improvement in return of gut function at 72 hours with perioperative IV lidocaine. Human results cannot settle the canine question, but they weaken the idea that improved bowel recovery is an established, predictable effect.

IV lidocaine remains a possible selected adjunct, with an explicit treatment goal and reassessment. It should not be presented as a proven solution for canine postoperative ileus.

Ketamine has supportive canine evidence but limited GI-specific evidence

Low-dose ketamine can contribute analgesia through mechanisms different from those of opioids. In a randomized, blinded study of 27 dogs undergoing forelimb amputation, adding a ketamine infusion to a protocol that included postoperative fentanyl produced lower pain scores at 12 and 18 hours. That supports a possible adjunctive role in dogs with substantial postoperative pain. It does not establish improved GI motility, anastomotic healing or a particular reduction in opioid requirements after intestinal surgery.

My reason to consider ketamine would be persistent pain or a need to broaden the analgesic approach, with monitoring appropriate to the patient. The goal should be observable comfort, rather than simply adding another infusion because the procedure involved the abdomen.

Gabapentin is an adjunct with mixed evidence

The evidence is more nuanced than either routine enthusiasm or blanket dismissal suggests. In a randomized trial involving 63 dogs undergoing hemilaminectomy, gabapentin added to background opioid treatment did not produce a statistically detectable reduction in postoperative pain behavior. The authors identified effective background analgesia and dose adequacy as possible explanations.

A separate randomized mastectomy study involving 20 dogs found fewer rescue morphine doses with gabapentin, although pain scores did not differ significantly. Those dogs also received morphine and meloxicam.

These are adjunct trials in other surgical populations. Neither establishes that gabapentin alone adequately controls visceral and incisional pain after major GI surgery.

The AAHA guidelines likewise emphasize the lack of established efficacy for acute canine pain. I would reserve gabapentin for a specific adjunctive indication rather than use it to replace a stronger analgesic simply because it is easy to dispense. A quieter dog still needs evaluation for pain.

Oral tramadol should not carry the discharge plan

AAHA substantially deemphasizes oral tramadol for postoperative analgesia in dogs and distinguishes it from the mixed evidence for injectable administration. Newer research adds nuance without establishing a dependable stand-alone option. A 2026 randomized trial assigned 30 dogs undergoing ovariohysterectomy with unilateral mastectomy to tramadol, dipyrone, or their combination. All also received other perioperative analgesics, including meloxicam. Some early pain outcomes favored the combination, but overall rescue analgesia frequency did not differ significantly among groups. This small, industry-funded study tested a multimodal regimen in a different surgical population. It does not validate tramadol alone after intestinal resection, and improvement with a combination cannot establish how much benefit came from each component.

My conclusion remains that oral tramadol alone is an inadequate evidence-based foundation for discharge analgesia after major canine GI surgery.

What about acetaminophen

Acetaminophen, also called paracetamol, deserves discussion when NSAIDs are unsuitable, but the canine evidence is inconsistent. A randomized study of 70 surgical patients found oral paracetamol/codeine non-inferior to meloxicam for several outcomes within a regimen that included methadone premedication and buprenorphine during the first postoperative day. It did not establish either the efficacy of acetaminophen alone or the safety of that approach after intestinal anastomosis.

Conversely, a small placebo-controlled trial found no detectable analgesic benefit from a single postoperative IV acetaminophen dose after ovariohysterectomy. A 2026 orthopedic study also found no significant opioid-sparing effect when IV paracetamol was added to multimodal treatment.

It may be considered by the treating veterinarian as a selected canine adjunct. The literature does not establish it as a universally effective substitute for opioids or NSAIDs after GI surgery. Owners should not add human pain medications themselves.

Discharge is an analgesic decision

The difficult practical question is what to do when a dog still needs substantial analgesia but an NSAID remains unsuitable and oral treatment is unreliable. My clinical conclusion is that discharge should depend partly on whether the intended home plan can maintain comfort. Continued monitored care may be appropriate when the dog still needs titrated parenteral analgesia. Medication availability should prompt planning, rather than an assumption that gabapentin or tramadol will fill the gap.

Before discharge, I would evaluate the patient on the intended regimen and arrange a clear reassessment plan. Persistent vomiting, worsening abdominal pain, distension or deterioration warrants evaluation for a complication as well as review of analgesia. Increasing medication is not a substitute for investigating a changing clinical picture.

Pain scoring turns a prescription into a treatment plan

The Glasgow Composite Measure Pain Scale Short Form was developed to support assessment of acute postoperative canine pain and provide an analgesic intervention score. It supplies structure, but clinical interpretation remains essential.

Sedation can complicate assessment. A randomized orthopedic study demonstrated that analgesic-associated behavioral changes could bias some subjective pain measures. A sleeping or quiet dog should not automatically be classified as comfortable.

For GI patients, my assessment would track pain alongside nausea, interaction, mobility when appropriate, hydration and the wider examination. Appetite is useful context, but it is not a pain score. The plan needs a rescue threshold, reassessment after treatment, and adjustment when the response differs from expectations.

What I would take from this literature

The strongest message is to match treatment to the patient and to the source of pain. Use an effective systemic analgesic when needed, add suitable local or regional techniques, and reassess NSAID eligibility as the patient’s condition changes.

The evidence supports restraint in our claims as well as care in our prescribing. Selected carprofen use has reassuring retrospective data, but safety in high-risk anastomoses remains uncertain. Postoperative lidocaine has a directly relevant negative canine trial. Ketamine has supportive evidence from other surgeries. Gabapentin and oral tramadol lack evidence as adequate sole treatment after major GI surgery. A multimodal plan succeeds when it provides measurable comfort with acceptable adverse effects. The number of drugs on the chart is not the outcome.

References

1. Monteiro BP, et al. 2022 WSAVA guidelines for the recognition, assessment and treatment of pain. J Small Anim Pract. 2023.

2. Epidural administration of morphine facilitates time of appearance of first gastric interdigestive migrating complex in dogs with paralytic ileus after open abdominal surgery. 2007.

3. Riddle E, Maritato KC, Schwartz SH. A retrospective analysis of postoperative gastrointestinal dehiscence and ileus in dogs receiving carprofen or not receiving carprofen following gastrointestinal surgery. J Small Anim Pract. 2025;66:665–669.

4. Klein M, et al. Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data. BMJ. 2012.

5. Paolini A, et al. Use of transversus abdominis plane and intercostal blocks in bitches undergoing laparoscopic ovariectomy: a randomized controlled trial. Vet Sci. 2022;9:604.

6.Campoy L, et al. Transverse abdominis plane injection of bupivacaine with dexmedetomidine or a bupivacaine liposomal suspension yielded lower pain scores and requirement for rescue analgesia in a controlled, randomized trial in dogs undergoing elective ovariohysterectomy. Am J Vet Res. 2022;83. 

7. Fumanelli E, et al. Perioperative analgesic efficacy of quadratus lumborum block versus transversus abdominis plane block in dogs undergoing laparoscopic ovariectomy: a prospective randomized clinical trial. Front Vet Sci. 2025;12:1613741.

8. Burns CC, et al. Pharmacokinetics and effect of postoperative lidocaine infusions on pain and nausea scores in canine patients undergoing gastrointestinal foreign body surgery. Am J Vet Res. 2025.

9. Intravenous lidocaine for gut function recovery in colonic surgery: a randomized clinical trial. ALLEGRO trial. JAMA.

10. Wagner AE, et al. Use of low doses of ketamine administered by constant rate infusion as an adjunct for postoperative analgesia in dogs. JAVMA. 2002;221:72–75.

11. Aghighi SA, et al. Assessment of the effects of adjunctive gabapentin on postoperative pain after intervertebral disc surgery in dogs. Vet Anaesth Analg. 2012;39:636–646. 

12. Crociolli GC, et al. Gabapentin as an adjuvant for postoperative pain management in dogs undergoing mastectomy. J Vet Med Sci. 2015;77:1011–1015.

13. Gruen ME, et al. 2022 AAHA Pain Management Guidelines for Dogs and Cats.

14. Mastrocinque S, et al. Efficacy and safety of a fixed-dose oral tramadol–dipyrone combination for postoperative analgesia in dogs undergoing ovariohysterectomy and unilateral mastectomy: a randomized clinical trial. Front Vet Sci. 2026.

15. Pacheco M, et al. Comparing paracetamol/codeine and meloxicam for postoperative analgesia in dogs: a non-inferiority trial. Vet Rec. 2020.

16. Intravenous acetaminophen does not provide adequate postoperative analgesia in dogs following ovariohysterectomy. 2021.

17. Intravenous paracetamol does not have significant opioid-sparing effects when used as part of a multimodal analgesic protocol in dogs undergoing elective orthopaedic surgery. 2026.

18. Reid J, et al. Development of the short-form Glasgow Composite Measure Pain Scale and derivation of an analgesic intervention score. Anim Welf. 2007.

19. Rialland P, et al. Validation of orthopedic postoperative pain assessment methods for dogs: a prospective, blinded, randomized, placebo-controlled study. PLoS One. 2012.